Global In Vitro Assays to Diagnose Infectious Diseases Supply, Demand and Key Producers, 2023-2029

Global In Vitro Assays to Diagnose Infectious Diseases Supply, Demand and Key Producers, 2023-2029

The global In Vitro Assays to Diagnose Infectious Diseases market size is expected to reach $ 3320.3 million by 2029, rising at a market growth of -1.3% CAGR during the forecast period (2023-2029).

Enzyme-Linked Immunosorbent Assay (ELISA): ELISA is a highly sensitive and specific assay that detects the presence of antigens or antibodies in patient samples. ELISA can be used to diagnose a wide range of infectious diseases, including HIV, hepatitis, and Lyme disease.

In Vitro Assays to Diagnose Infectious Diseases market refers to the use of diagnostic tests and devices to detect and diagnose infectious diseases in biological samples such as blood, urine, and other bodily fluids. These tests are performed in vitro, meaning outside of the body in a laboratory setting. The IVD market for infectious diseases includes a range of tests such as immunoassays, molecular diagnostics, and microbiology culture tests, among others. These tests aid in the identification of infectious agents such as bacteria, viruses, fungi, and parasites, and help in the management and treatment of infectious diseases.

This report studies the global In Vitro Assays to Diagnose Infectious Diseases demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for In Vitro Assays to Diagnose Infectious Diseases, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of In Vitro Assays to Diagnose Infectious Diseases that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global In Vitro Assays to Diagnose Infectious Diseases total market, 2018-2029, (USD Million)

Global In Vitro Assays to Diagnose Infectious Diseases total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: In Vitro Assays to Diagnose Infectious Diseases total market, key domestic companies and share, (USD Million)

Global In Vitro Assays to Diagnose Infectious Diseases revenue by player and market share 2018-2023, (USD Million)

Global In Vitro Assays to Diagnose Infectious Diseases total market by Type, CAGR, 2018-2029, (USD Million)

Global In Vitro Assays to Diagnose Infectious Diseases total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global In Vitro Assays to Diagnose Infectious Diseases market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include QIAGEN, BD, bioMerieux SA, F. Hoffmann-La Roche, Ltd., Hologic, Inc. (Gen-Probe), Abbott, Quidel Corp.、, iemens Healthineers AG and Bio-Rad Laboratories, Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World In Vitro Assays to Diagnose Infectious Diseases market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global In Vitro Assays to Diagnose Infectious Diseases Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global In Vitro Assays to Diagnose Infectious Diseases Market, Segmentation by Type
Immunoassay
Molecular Diagnosis
Others

Global In Vitro Assays to Diagnose Infectious Diseases Market, Segmentation by Application
Streptococcus
Clostridium Difficile
Candida
Tuberculosis
Others

Companies Profiled:
QIAGEN
BD
bioMerieux SA
F. Hoffmann-La Roche, Ltd.
Hologic, Inc. (Gen-Probe)
Abbott
Quidel Corp.、
iemens Healthineers AG
Bio-Rad Laboratories, Inc.
Danaher Corp.
OraSure Technologies, Inc

Key Questions Answered

1. How big is the global In Vitro Assays to Diagnose Infectious Diseases market?

2. What is the demand of the global In Vitro Assays to Diagnose Infectious Diseases market?

3. What is the year over year growth of the global In Vitro Assays to Diagnose Infectious Diseases market?

4. What is the total value of the global In Vitro Assays to Diagnose Infectious Diseases market?

5. Who are the major players in the global In Vitro Assays to Diagnose Infectious Diseases market?

6. What are the growth factors driving the market demand?